Pharma Stocks
-
Amylyx Pharmaceuticals Shares Rise 6.9% on Positive News
Got story updates? Submit your updates here. › The advanced machinery and engineering behind Amylyx Pharmaceuticals’ promising neurological drug pipeline.Cambridge…
Read More » -
Zacks Industry Outlook Highlights Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics and Avalo Therapeutics – April 6, 2026
For Immediate Release Chicago, IL – April 6, 2026 – Today, Zacks Equity Research discusses Indivior Pharmaceuticals (INDV Quick QuoteINDV…
Read More » -
Pharma, Auto, and IT: Pankaj Pandey shares sectoral insights amid global challenges
With ongoing developments in US tariffs and a volatile market backdrop, investors are keen to understand sector-specific impacts and opportunities.…
Read More » -
How Investors May Respond To Shionogi (TSE:4507) Acquiring Full RADICAVA Rights And Expanding In Rare Disease
Shionogi & Co., Ltd. has completed the acquisition of all rights to the ALS treatment RADICAVA (edaravone) from Tanabe Pharma,…
Read More » -
Clipping a 12% Coupon on a Big Pharma Name
Clipping coupons Investors finally saw a rebound in equities during the holiday shortened trading week after five straight weeks of…
Read More » -
A Look At ACADIA Pharmaceuticals (ACAD) Valuation As Shares Trade Near Recent Levels
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply…
Read More » -
Assessing Zealand Pharma (CPSE:ZEAL) Valuation After New AI-Focused Cambridge Research Hub Announcement
Zealand Pharma (CPSE:ZEAL) recently announced a new research hub in Cambridge, Massachusetts. This facility will become its primary U.S. base…
Read More » -
We’re Keeping An Eye On Cocrystal Pharma’s (NASDAQ:COCP) Cash Burn Rate
Just because a business does not make any money, does not mean that the stock will go down. For example,…
Read More » -
We’re Keeping An Eye On Cocrystal Pharma’s (NASDAQ:COCP) Cash Burn Rate
There’s no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com made losses…
Read More » -
Assessing Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After New SUBLOCADE Cost Savings Evidence In Corrections Settings
Indivior Pharmaceuticals (INDV) is back in focus after a new peer reviewed cost impact model suggested its monthly SUBLOCADE injection…
Read More »